PS Ratio Chart

View PS Ratio for BVNRY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View PS Ratio Chart
Start Trial

Historical PS Ratio Data

View and export this data back to 2014. Start Trial.
Date Value
August 25, 2026 2.682
August 24, 2026 2.626
August 21, 2026 2.586
August 20, 2026 2.367
August 19, 2026 2.373
August 18, 2026 2.314
August 17, 2026 2.292
August 14, 2026 2.269
August 13, 2026 2.216
August 12, 2026 2.198
August 11, 2026 2.147
August 10, 2026 2.147
August 07, 2026 2.162
August 06, 2026 2.183
August 05, 2026 2.183
August 04, 2026 2.183
August 03, 2026 2.186
July 31, 2026 2.169
July 30, 2026 2.152
July 29, 2026 2.140
July 28, 2026 2.140
July 27, 2026 2.096
July 24, 2026 2.083
July 23, 2026 2.119
July 22, 2026 2.188
Date Value
July 21, 2026 2.188
July 20, 2026 2.201
July 17, 2026 2.225
July 16, 2026 2.256
July 15, 2026 2.219
July 14, 2026 2.207
July 13, 2026 2.174
July 10, 2026 2.212
July 09, 2026 2.238
July 08, 2026 2.264
July 07, 2026 2.319
July 06, 2026 2.319
July 02, 2026 2.284
July 01, 2026 2.223
June 30, 2026 2.216
June 29, 2026 2.367
June 26, 2026 2.319
June 25, 2026 2.308
June 24, 2026 2.292
June 23, 2026 2.299
June 22, 2026 2.286
June 18, 2026 2.352
June 17, 2026 2.355
June 16, 2026 2.376
June 15, 2026 2.432

Price to Sales Ratio Definition

The Price to Sales Ratio (PS Ratio) is calculated by taking the stock price / revenue per share (ttm). This metric is considered a valuation metric that confirms whether the sales of a company justifies the stock price. There isn't necesarily an optimum PS ratio, since different industries will have different ranges of PS Ratios. Because of this, PS Ratio is great to evaluate from a relative standpoint with other similar companies. PS Ratio might also be a handy metric for companies that are not profitable yet, since they might be valued moreso by their overall sales and potential of becoming profitable in the future.

Read full definition.

PS Ratio Range, Past 5 Years

View PS Ratio Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

PS Ratio Benchmarks

View PS Ratio Benchmarks
Start Trial
Evaxion AS 3.331
Genmab A/S 5.305
Ascendis Pharma A/S 13.21
Zealand Pharma A/S 5.060
Agenus, Inc. 2.328

PS Ratio Related Metrics